ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,839, issued on Jan. 20, was assigned to Acceleron Pharma Inc. (Cambridge, Mass.).
"Treatments for systemic sclerosis" was invented by Gang Li (Cambridge, Mass.), Janethe De Oliveira Pena (Cambridge, Mass.), Ravindra Kumar (Cambridge, Mass.) and Joseph Grattin Reynolds (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In certain aspects, the present disclosure relates to methods of treating systemic sclerosis (SSc) using TBetaRII antagonists comprising a heterologous domain and a truncated, ligand-binding portion of the extracellular domain of TBetaRII polypeptide useful to selectively antagonize a TBetaRII ligand. The disclosure furth...